By performing IHC testing on multi-cancerous tissue microarray, we found that the expression of ACVRL1 is significantly higher in CRC when compared with most mTKI-sensitive tumours (HCC, RCC, etc.)(Fig. 1F). This evidence concerns the gene ACVRL1 and colorectal carcinoma.